Your browser doesn't support javascript.
loading
Chemotherapeutic potential of lupeol against cancer in pre-clinical model: A systematic review and meta-analysis.
Fatma, Homa; Jameel, Mohd; Siddiqui, Arif Jamal; Kuddus, Mohammed; Buali, Nouha Saleh; Bahrini, Insaf; Siddique, Hifzur R.
Affiliation
  • Fatma H; Molecular Cancer Genetics & Translational Research Laboratory, Section of Genetics, Department of Zoology, Aligarh Muslim University, Aligarh-202002, Uttar Pradesh, India.
  • Jameel M; Molecular Cancer Genetics & Translational Research Laboratory, Section of Genetics, Department of Zoology, Aligarh Muslim University, Aligarh-202002, Uttar Pradesh, India.
  • Siddiqui AJ; Department of Biology, College of Science, University of Ha'il, Hail, PO Box 2440, Kingdom of Saudi Arabia. Electronic address: arifjamal13@gmail.com.
  • Kuddus M; Department of Biochemistry, College of Medicine, University of Ha'il, Hail, Kingdom of Saudi Arabia.
  • Buali NS; Department of Biology, College of Science, University of Ha'il, Hail, PO Box 2440, Kingdom of Saudi Arabia.
  • Bahrini I; Department of Biology, College of Science, University of Ha'il, Hail, PO Box 2440, Kingdom of Saudi Arabia.
  • Siddique HR; Molecular Cancer Genetics & Translational Research Laboratory, Section of Genetics, Department of Zoology, Aligarh Muslim University, Aligarh-202002, Uttar Pradesh, India. Electronic address: hifzur.zo@amu.ac.in.
Phytomedicine ; 132: 155777, 2024 Sep.
Article de En | MEDLINE | ID: mdl-38943695
ABSTRACT

BACKGROUND:

Extensive research on Lupeol's potential in cancer prevention highlights its ability to target various cancer-related factors. It regulates proliferative markers, modulates signaling pathways, including PI3K/AKT/mTOR, and influences inflammatory and apoptotic mechanisms. Additionally, Lupeol demonstrates selectivity in killing cancer cells while sparing normal cells, thus minimizing the risk of toxic effects on healthy tissues.

HYPOTHESIS:

Therefore, we aimed to explore Lupeol's potential roles as a chemotherapeutic agent and as a sensitizer to chemotherapy by reviewing various animal-based studies published on its effects. STUDY

DESIGN:

We conducted a comprehensive search across databases, including PubMed, PMC, Cochrane, EuroPMC, and ctri.gov.in to identify pertinent articles. Our focus was solely on published animal studies examining Lupeol's anti-cancer effects, with reviewers independently assessing bias risk and resolving discrepancies through consensus.

RESULT:

20 studies were shortlisted. The results demonstrated that Lupeol brings changes in the tumor volume by [Hedges's g -6.62; 95 % CI -8.68, -4.56; τ2 24.36, I2 96.50 %; p < 0.05] and tumor weight by [Hedges's g -3.97; 95 % CI -5.20, -2.49; τ2 2.70, I2 79.27 %; p <0.05]. The high I2, negative Egger's value, and asymmetrical funnel plot show the publication bias among the studies. Further, Lupeol in combination with other chemotherapeutic agents showed better outcomes as compared to them alone [Hedges's g -6.38; 95 % CI -11.82, -0.94; τ2 46.91; I2 98.68 %; p <0.05]. Lupeol also targets various signaling molecules and pathways to exert an anti-cancer effect.

CONCLUSION:

In conclusion, Lupeol significantly reduces tumor volume and weight. Combining Lupeol with other chemotherapy agents shows promise for enhancing anti-cancer effects. However, high variability among studies and evidence of publication bias suggest caution in interpreting results.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Triterpènes pentacycliques / Tumeurs Limites: Animals / Humans Langue: En Journal: Phytomedicine Sujet du journal: TERAPIAS COMPLEMENTARES Année: 2024 Type de document: Article Pays d'affiliation: Inde Pays de publication: Allemagne

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Triterpènes pentacycliques / Tumeurs Limites: Animals / Humans Langue: En Journal: Phytomedicine Sujet du journal: TERAPIAS COMPLEMENTARES Année: 2024 Type de document: Article Pays d'affiliation: Inde Pays de publication: Allemagne